Neuroinflammation in Ocular Diseases: Emerging Insights into Mechanisms, Biomarkers, and Therapeutic Targets
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biomarkers".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 1452
Special Issue Editor
Interests: retina; ischemic retinopathy; neurovascular injury; neurodegeneration; oxidative stress; polyamine oxidase
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neuroinflammation is increasingly recognized as a critical component in ocular diseases, including diabetic retinopathy, glaucoma, optic neuritis, and optic neuropathies. These diseases impact millions of individuals globally and present complex and multifaceted pathologies affecting the retina, optic nerve, or both. The precise mechanisms driving neuroinflammation in these conditions are still not fully understood, complicating efforts to develop effective therapies. This Special Issue is dedicated to advancing our knowledge of the neuroinflammatory processes in ocular diseases. We seek to highlight recent breakthroughs in understanding the mechanisms and efforts to identify novel biomarkers and therapeutic targets. By fostering research in these areas, we aim to contribute to the development of innovative, targeted treatments that could significantly improve outcomes for patients affected by these challenging conditions.
Dr. S. Priya Narayanan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroinflammation
- vision
- retina
- optic nerve
- neurodegeneration
- inflammation
- biomarker
- therapeutic strategies
- pharmacological treatments
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
